COVID-19 vaccination: effective utilization of low dead space (LDS) syringes

In the spring 2021, the only available vaccine for COVID-19 was the Pfizer-BioNTech mRNA COVID-19 vaccine (Polack et al., 2020), which was in limited supply in Japan. Also, it was difficult to procure specialized low dead space (LDS) syringes that can extract the full six doses from each vial of the Pfizer vaccine. When the Government provided the Pfizer vaccine to health care workers in our hospital, 1,242 candidates applied for their first shot. However, the use of regular syringes with high dead space meant that only five of the six doses could be extracted from each vial.

Source: International Journal of Infectious Diseases - September 28, 2021 Category: Infectious Diseases Authors: Jun Shinozuka, Michiaki Hata, Hiromi Eguchi, Masahiro Mori, Mitsunori Eguchi, Mototaka Fukui, Natsuki Sai, Shinsaku Imashuku, Atsushi Sueyoshi Tags: Short Communication Source Type: research